| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks | Director
2 companies
Von Moltke Lisa is a Director at TVRD with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 7 sells.
Estimated insider holdings value: $757K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 18, 2025 | MCRB Seres Therapeutics, Inc. | See Remarks | Sale+OE | 4,416 | $0.81 | $3,579.17 | -10.0% | -52.0% | -50.5% | |
| Nov 18, 2024 | MCRB Seres Therapeutics, Inc. | See Remarks | Sale+OE | 977 | $0.54 | $528.26 | -2.9% | +43.6% | +113.4% | |
| Oct 28, 2024 | MCRB Seres Therapeutics, Inc. | See Remarks | Sale+OE | 4,334 | $0.69 | $2,991.33 | -12.5% | +20.2% | +22.6% | |
| Aug 16, 2024 | MCRB Seres Therapeutics, Inc. | See Remarks | Sale+OE | 973 | $0.84 | $817.32 | -4.4% | -32.7% | -5.1% | |
| May 15, 2024 | MCRB Seres Therapeutics, Inc. | See Remarks | Sale+OE | 939 | $0.94 | $882.66 | -4.7% | -13.6% | -61.3% | |
| Feb 16, 2024 | MCRB Seres Therapeutics, Inc. | See Remarks | Sale+OE | 4,400 | $1.08 | $4,752.00 | -20.6% | -12.0% | -20.7% | |
| Oct 30, 2023 | MCRB Seres Therapeutics, Inc. | See Remarks | Sale+OE | 4,232 | $1.35 | $5,713.20 | -30.8% | -13.8% | -46.8% |